Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Destiny Pharma. (DEST)

Price 16.25p on 26-04-2024 at 16:30:01
Change -0.50p -2.99%
Buy 16.50p
Sell 16.00p
Buy / Sell DEST Shares
Last Trade: Unknown 11,200.00 at 16.25p
Day's Volume: 1,536,814
Last Close: 16.25p
Open: 16.75p
ISIN: GB00BDHSP575
Day's Range 14.80p - 16.25p
52wk Range: 14.50p - 82.00p
Market Capitalisation: £15m
VWAP: 15.81228p
Shares in Issue: 95m

Recent Trades History Destiny Pharma. (DEST)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 11,200 16.25p OTC Trade
16:06:11 - 26-Apr-24
Sell* 21,465 16.17p Ordinary
15:25:09 - 26-Apr-24
Buy* 19 16.50p Ordinary
15:22:48 - 26-Apr-24
Buy* 24,605 16.28p Ordinary
15:22:45 - 26-Apr-24
Buy* 1,700 16.415p Ordinary
15:09:41 - 26-Apr-24
Buy* 10,000 16.47p Ordinary
15:08:03 - 26-Apr-24
Unknown* 25,000 16.25p Ordinary
15:04:59 - 26-Apr-24
Buy* 296 16.50p SI Trade
15:04:28 - 26-Apr-24
Buy* 303 16.50p SI Trade
15:04:28 - 26-Apr-24
Buy* 20,000 16.40p Ordinary
15:04:20 - 26-Apr-24

Share Price History for Destiny Pharma.

Time period:
to
Date Open High Low Close Volume

Share News for Destiny Pharma.

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

25th Apr 2024 20:57

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract

25th Apr 2024 10:23

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

UK earnings, trading statements calendar - next 7 days

18th Apr 2024 14:17

Read More

EARNINGS AND TRADING: STV raises holding in Two Cities Television

31st Jan 2024 18:28

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Destiny Pharma seeks to capitalise on XF-73 market potential in 2024

4th Jan 2024 14:07

(Alliance News) - Destiny Pharma PLC on Thursday said that its priority remains promoting its XF-73 Nasal antibacterial drug. Read More

FTSE 100 Latest
Value8,139.83
Change60.97

Login to your account

Forgot Password?

Not Registered